Abstract
Soy consumption during pregnancy has increased substantially in Western countries, driven by the rise of plant-based diets, the growing use of soy-based food products, and increasing awareness of environmental and health considerations related to animal protein consumption. Soy foods contain isoflavones — phytoSERMs with structural and functional similarities to endogenous estrogens — which raises specific questions regarding their safety and potential biological effects during pregnancy, a period of heightened hormonal sensitivity and critical developmental programming. Despite a substantial body of literature on isoflavones in non-pregnant populations, the evidence specifically relating to dietary soy exposure during pregnancy remains heterogeneous, scattered across disciplines (nutrition, obstetrics, endocrinology, epidemiology), and has not been systematically mapped. Regulatory assessments, including recent opinions from ANSES and ongoing deliberations at the European Food Safety Authority (EFSA), have highlighted the need for a clearer picture of the available evidence base in this population. This scoping review aims to systematically map the existing literature on dietary soy exposure — including whole soy foods, soy-derived ingredients, and isoflavone-containing products consumed through diet — and its association with pregnancy outcomes in pregnant women across all trimesters. Outcomes of interest include, but are not limited to: gestational duration, birth weight and anthropometric parameters, thyroid function, pregnancy complications (gestational diabetes, preeclampsia, preterm birth), and hormonal profiles. The review will follow the PRISMA extension for Scoping Reviews (PRISMA-ScR) framework and the methodological guidance of Arksey and O'Malley, as refined by Levac and colleagues. Searches will be conducted in PubMed/MEDLINE, Embase, and OpenAlex. Both observational studies (cohort, case-control, cross-sectional) and interventional studies will be eligible for inclusion. No language or date restrictions will be applied a priori. The expected outcome of this review is a comprehensive map of the scope, nature, and distribution of evidence on dietary soy intake during pregnancy, identification of key concepts and study characteristics, and the delineation of research gaps that may inform future systematic reviews or primary research priorities. This work is intended to support evidence-based nutritional guidance for pregnant women and contribute to ongoing regulatory and scientific discussions at the national and European levels.